48169-7 |
Amikacin 1.5 ug/mL |
Susc |
Isolate |
Pt |
OrdQn |
Method for Slow-growing mycobacteria |
|
ACTIVE |
Amikacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
48169-7 |
|
Method for Slow-growing mycobacteria |
|
|
Observation |
|
|
|
0 |
Amikacin 1.5 ug/mL Islt SlowMyco |
|
|
|
N |
|
AFB; Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis |
2.4 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
4817-3 |
HLA-B18 |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-B18 [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4817-3 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-B18 Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
48170-5 |
Capreomycin 3.0 ug/mL |
Susc |
Isolate |
Pt |
OrdQn |
Method for Slow-growing mycobacteria |
|
ACTIVE |
Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
48170-5 |
|
Method for Slow-growing mycobacteria |
|
|
Both |
|
|
|
0 |
Capreomycin 3 ug/mL Islt SlowMyco |
|
|
|
N |
|
3 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; CAPASTAT; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Ogostal; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis |
2.26 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
48171-3 |
Isoniazid 0.1 ug/mL |
Susc |
Isolate |
Pt |
OrdQn |
Slow-growing Mycobacteria |
|
DEPRECATED |
Deprecated Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
48171-3 |
|
Slow-growing Mycobacteria |
|
|
Both |
|
|
|
0 |
Deprecated Isoniazid 0.1 ug/mL Islt Slow |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Hyzyd; ID; Infectious Disease; InfectiousDisease; INH; Islt; Isol; Isoniaz; Isoniazide; mcg; Nudrazod; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.36 |
2.21 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
48172-1 |
Isoniazid 0.4 ug/mL |
Susc |
Isolate |
Pt |
OrdQn |
Slow-growing Mycobacteria |
|
DEPRECATED |
Deprecated Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
48172-1 |
|
Slow-growing Mycobacteria |
|
|
Both |
|
|
|
0 |
Deprecated Isoniazid 0.4 ug/mL Islt Slow |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Hyzyd; ID; Infectious Disease; InfectiousDisease; INH; Islt; Isol; Isoniaz; Isoniazide; mcg; Nudrazod; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.36 |
2.21 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
48173-9 |
levoFLOXacin 1.5 ug/mL |
Susc |
Isolate |
Pt |
OrdQn |
Method for Slow-growing mycobacteria |
|
ACTIVE |
levoFLOXacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
48173-9 |
|
Method for Slow-growing mycobacteria |
|
|
Both |
|
|
|
0 |
levoFLOXacin 1.5 ug/mL Islt SlowMyco |
|
|
|
N |
|
AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis |
2.26 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
48174-7 |
Mycobacterium tuberculosis complex rRNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Mycobacterium tuberculosis complex rRNA [Presence] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
TB complex detected, TB complex not detected, Sample unsatisfactory |
|
|
|
|
|
MICRO |
|
48174-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
M TB Cmplx rRNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Compx; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M tb; M TB Cmplx; M tuberculosis; Microbiology; Misc; Miscellaneous; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Spec; Strand Displacement Amplification; TB; TMA; To be specified in another part of the message; Transcription mediated amplification; Tuberculosis; Unspecified |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
48175-4 |
Mycobacterium tuberculosis katG+inhA genes isoniazid resistance mutation |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Mycobacterium tuberculosis katG + inhA gene isoniazid resistance mutation [Presence] by Molecular method |
|
NAM |
DefinitionDescription |
|
|
|
Mutation detected, Mutation Not detected |
|
|
|
|
|
ABXBACT |
|
48175-4 |
|
Molgen |
|
|
Both |
|
|
|
0 |
MTB katG+inhA INH h res mut Islt/Spm Ql |
|
|
|
N |
|
Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; Hyzyd; ID; Infectious Disease; InfectiousDisease; INH; Islt; Islt/Spm; Isol; Isoniaz; Isoniazide; M tb; M tuberculosis; Molecular genetics; Mtb; MTB katG+inhA INH h res mut; Mut; Mutations; Myco; Mycobact; Mycobacterium tuberculosum; Nudrazod; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; TB; Tuberculosis |
2.65 |
2.21 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; Updated Component to reflect that katG and inhA are native genes in which a mutation causes fluoroquinolone resistance, System from "XXX", and Method from "Probe.amp.tar" according to the new sustainable model for LOINC molecular resistance terms [Approved by LOINC Laboratory Committee in June 2018]. |
0 |
48176-2 |
Mycobacterium tuberculosis rifAMPin resistance (rpoB) gene |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
DEPRECATED |
Deprecated Mycobacterium tuberculosis rifAMPin resistance (rpoB) gene [Presence] in Unspecified specimen by NAA with probe detection |
|
DEL |
DefinitionDescription |
|
|
|
Mutation detected, Mutation Not detected |
|
|
|
|
|
ABXBACT |
|
48176-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Deprecated M TB rpoB XXX Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; c301; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M tb; M tuberculosis; Misc; Miscellaneous; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; RIF; Rifadin; Rifampicin; Rimactane; Screen; SDA; Spec; Strand Displacement Amplification; TB; TMA; To be specified in another part of the message; Transcription mediated amplification; Tuberculosis; Unspecified |
2.64 |
2.21 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
48177-0 |
Streptomycin 1.0 ug/mL |
Susc |
Isolate |
Pt |
OrdQn |
Method for Slow-growing mycobacteria |
|
ACTIVE |
Streptomycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
48177-0 |
|
Method for Slow-growing mycobacteria |
|
|
Both |
|
|
|
0 |
Streptomycin 1 ug/mL Islt SlowMyco |
|
|
|
N |
|
1 ug/mL; AFB; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; c232; C295; Cidam est; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Novostrep; Point in time; Random; SlowMyco; Solustrep; Streptocol; Strepto-fatol; Streptomyc; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
48178-8 |
Reference change value 0.99 |
Num |
^Population |
XXX |
Qn |
|
|
ACTIVE |
Reference change value 0.99 [#] in unspecified time Population |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
NR STATS |
|
48178-8 |
|
|
|
|
Observation |
|
|
|
0 |
RCV 0.99 ?Tm Pop |
|
|
|
N |
|
?Tm; Cnt; Count; Exchange; NR Stats; Number; QNT; Quan; Quant; Quantitative; RCV 0.99; Replace |
2.27 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
48179-6 |
Reference change value 0.99 |
NFr |
^Population |
XXX |
Qn |
|
|
ACTIVE |
Reference change value 0.99 in unspecified time Population |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
NR STATS |
|
48179-6 |
|
|
|
|
Observation |
|
|
|
0 |
RCV 0.99 ?Tm NFr Pop |
|
|
|
N |
|
?Tm; Exchange; NR Stats; Number Fraction; Percent; QNT; Quan; Quant; Quantitative; RCV 0.99; Replace |
2.4 |
2.21 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
4818-1 |
HLA-B21 |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-B21 [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4818-1 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-B21 Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
48180-4 |
Reference change value 0.95 |
NFr |
^Population |
XXX |
Qn |
|
|
ACTIVE |
Reference change value 0.95 in unspecified time Population |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
NR STATS |
|
48180-4 |
|
|
|
|
Observation |
|
|
|
0 |
RCV 0.95 ?Tm NFr Pop |
|
|
|
N |
|
?Tm; Exchange; NR Stats; Number Fraction; Percent; QNT; Quan; Quant; Quantitative; RCV 0.95; Replace |
2.4 |
2.21 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
48181-2 |
Reference change value 0.95 |
Num |
^Population |
XXX |
Qn |
|
|
ACTIVE |
Reference change value 0.95 [#] in unspecified time Population |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
NR STATS |
|
48181-2 |
|
|
|
|
Observation |
|
|
|
0 |
RCV 0.95 ?Tm Pop |
|
|
|
N |
|
?Tm; Cnt; Count; Exchange; NR Stats; Number; QNT; Quan; Quant; Quantitative; RCV 0.95; Replace |
2.69 |
2.21 |
|
|
|
|
|
|
|
{#} |
|
|
|
0 |
48182-0 |
Vespa crabro leukotriene release |
MCnc |
WBC |
Pt |
Qn |
|
|
ACTIVE |
European Hornet triggered leukotriene release [Mass/volume] by Leukocytes |
|
MIN |
DefinitionDescription |
|
|
pg/mL sLT |
|
|
|
|
|
|
ALLERGY |
|
48182-0 |
|
|
|
|
Both |
|
|
|
0 |
European Hornet LR-mCnc |
|
|
|
N |
|
Allergen; Allergens; ALLERGY TESTING; CAST; European hornet; i75; Leukocytes; Level; LR; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.7 |
2.21 |
|
|
|
|
|
|
|
pg/mL{sLT} |
|
|
|
0 |
48183-8 |
Polistes spp leukotriene release |
MCnc |
WBC |
Pt |
Qn |
|
|
ACTIVE |
Paper wasp triggered leukotriene release [Mass/volume] by Leukocytes |
|
MIN |
DefinitionDescription |
|
|
pg/mL sLT |
|
|
|
|
|
|
ALLERGY |
|
48183-8 |
|
|
|
|
Both |
|
|
|
0 |
Paper Wasp LR-mCnc |
|
|
|
N |
|
Allergen; Allergens; ALLERGY TESTING; CAST; i004; i4; Leukocytes; Level; LR; Mass Concentration; Paper wasp; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.7 |
2.21 |
|
|
|
|
|
|
|
pg/mL{sLT} |
|
|
|
0 |
48184-6 |
Vespula spp leukotriene release |
MCnc |
WBC |
Pt |
Qn |
|
|
ACTIVE |
Yellow Jacket triggered leukotriene release [Mass/volume] by Leukocytes |
|
MIN |
DefinitionDescription |
|
|
pg/mL sLT |
|
|
|
|
|
|
ALLERGY |
|
48184-6 |
|
|
|
|
Both |
|
|
|
0 |
Yellow Jacket LR-mCnc |
|
|
|
N |
|
Allergen; Allergens; ALLERGY TESTING; CAST; Common wasp; i003; i3; Leukocytes; Level; LR; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Vespula sp; WBCs; White blood cells; Yellow jacket; Yellow wasp |
2.7 |
2.21 |
|
|
|
|
|
|
|
pg/mL{sLT} |
|
|
|
0 |
48185-3 |
Apis mellifera leukotriene release |
MCnc |
WBC |
Pt |
Qn |
|
|
ACTIVE |
Honey bee triggered leukotriene release [Mass/volume] by Leukocytes |
|
MIN |
DefinitionDescription |
|
|
pg/mL sLT |
|
|
|
|
|
|
ALLERGY |
|
48185-3 |
|
|
|
|
Both |
|
|
|
0 |
Honey bee LR-mCnc |
|
|
|
N |
|
Allergen; Allergens; ALLERGY TESTING; CAST; Honey bee; Honeybee; i001; i1; Leukocytes; Level; LR; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.7 |
2.21 |
|
|
|
|
|
|
|
pg/mL{sLT} |
|
|
|
0 |
48186-1 |
Amylase leukotriene release |
MCnc |
WBC |
Pt |
Qn |
|
|
ACTIVE |
Amylase triggered leukotriene release [Mass/volume] by Leukocytes |
|
MIN |
DefinitionDescription |
|
|
pg/mL sLT |
|
|
|
|
|
|
ALLERGY |
|
48186-1 |
|
|
|
|
Both |
|
|
|
0 |
Amylase LR-mCnc |
|
|
|
N |
|
Allergen; Allergens; ALLERGY TESTING; Alpha amylase; Ams; Amyl; CAST; Diastase; k87; Leukocytes; Level; LR; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.7 |
2.21 |
|
|
|
|
|
|
|
pg/mL{sLT} |
|
|
|
0 |
48187-9 |
Chloramin T leukotriene release |
MCnc |
WBC |
Pt |
Qn |
|
|
ACTIVE |
Chloramin T triggered leukotriene release [Mass/volume] by Leukocytes |
|
MIN |
DefinitionDescription |
|
|
pg/mL sLT |
|
|
|
|
|
|
ALLERGY |
|
48187-9 |
|
|
|
|
Both |
|
|
|
0 |
Chloramin T LR-mCnc |
|
|
|
N |
|
Allergen; Allergens; ALLERGY TESTING; CAST; Chloramine T; k85; Leukocytes; Level; LR; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; T prime; WBCs; White blood cells |
2.7 |
2.21 |
|
|
|
|
|
|
|
pg/mL{sLT} |
|
|
|
0 |
48188-7 |
Latex leukotriene release |
MCnc |
WBC |
Pt |
Qn |
|
|
ACTIVE |
Latex triggered leukotriene release [Mass/volume] by Leukocytes |
|
MIN |
DefinitionDescription |
|
|
pg/mL sLT |
|
|
|
|
|
|
ALLERGY |
|
48188-7 |
|
|
|
|
Both |
|
|
|
0 |
Ltx LR-mCnc |
|
|
|
N |
|
Allergen; Allergens; ALLERGY TESTING; CAST; Hevea braziliensis; k082; k82; Leukocytes; Level; LR; Ltx; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.7 |
2.21 |
|
|
|
|
|
|
|
pg/mL{sLT} |
|
|
|
0 |
48189-5 |
Formaldehyde leukotriene release |
MCnc |
WBC |
Pt |
Qn |
|
|
ACTIVE |
Formaldehyde triggered leukotriene release [Mass/volume] by Leukocytes |
|
MIN |
DefinitionDescription |
|
|
pg/mL sLT |
|
|
|
|
|
|
ALLERGY |
|
48189-5 |
|
|
|
|
Both |
|
|
|
0 |
Formaldehyde LR-mCnc |
|
|
|
N |
|
Allergen; Allergens; ALLERGY TESTING; CAST; Formalin; k80; Leukocytes; Level; LR; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.7 |
2.21 |
|
|
|
|
|
|
|
pg/mL{sLT} |
|
|
|
0 |
4819-9 |
HLA-B21 |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-B21 [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4819-9 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-B21 Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
48190-3 |
Phthalic anhydride leukotriene release |
MCnc |
WBC |
Pt |
Qn |
|
|
ACTIVE |
Phthalic anhydride triggered leukotriene release [Mass/volume] by Leukocytes |
|
MIN |
DefinitionDescription |
|
|
pg/mL sLT |
|
|
|
|
|
|
ALLERGY |
|
48190-3 |
|
|
|
|
Both |
|
|
|
0 |
PAN LR-mCnc |
|
|
|
N |
|
1,2-benzenedicarboxylic acid anhydride; 1,2-benzenedicarboxylic anhydride; 1,3-dioxophthalan; 1,3-isobenzofurandione; 1,3-phthalandione; Allergen; Allergens; ALLERGY TESTING; Anhydrid; CAST; k79; Leukocytes; Level; LR; Mass Concentration; PAN; Phthalandione; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.7 |
2.21 |
|
|
|
|
|
|
|
pg/mL{sLT} |
|
|
|
0 |